Wednesday, October 14, 2020 5:46:20 PM
Relief has no Assets except intangibles, It has no revenue stream for which to value a higher share price The ONLY thing Relief has is RLF-100. The company has put all it's eggs in this basket now...
On the other hand It also has no Debt to Service...making it very attractive because all the revenues from RLF-100 will make the company profitable very quickly. And that is why fundamentally the price has stalled at $0.5550 it's a large risk for investors to buy much higher than hear without news of Understanding or the Drug. And without a well respected research scientist leading the way Like Dr Javitts we wouldn't remain at $0.5550 for long fundamentally
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM